| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8474869 | Journal of Molecular and Cellular Cardiology | 2014 | 9 Pages |
Abstract
Using a broad spectrum of morphological, molecular, and functional parameters, we conclude that T3 is a driver for hiPSC-CM maturation. T3 treatment may enhance the utility of hiPSC-CMs for therapy, disease modeling, or drug/toxicity screens.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Xiulan Yang, Marita Rodriguez, Lil Pabon, Karin A. Fischer, Hans Reinecke, Michael Regnier, Nathan J. Sniadecki, Hannele Ruohola-Baker, Charles E. Murry,